NEUROCRINE BIOSCIENCES INC (NBIX) /
The profitability of NEUROCRINE BIOSCIENCES INC over the past 10 years
Chart NEUROCRINE BIOSCIENCES INC: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →NEUROCRINE BIOSCIENCES INC reported net income of $478.6M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $2.81B and operating income of $619.1M. It reported a profit in 8 of the 10 years shown, and a loss in fiscal 2016 and 2017.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $2.81B* | $619.1M | $478.6M |
| 2024ended Dec 31, 2024 | $2.32B* | $570.5M | $341.3M |
| 2023ended Dec 31, 2023 | $1.85B* | $250.9M | $249.7M |
| 2022ended Dec 31, 2022 | $1.47B* | $249M | $154.5M |
| 2021ended Dec 31, 2021 | $1.12B* | $102.5M | $89.6M |
| 2020ended Dec 31, 2020 | $1.04B* | $163M | $407.3M |
| 2019ended Dec 31, 2019 | — | $72.3M | $37M |
| 2018ended Dec 31, 2018 | $446.31M* | $36.8M | $21.1M |
| 2017ended Dec 31, 2017 | $160.37M* | -$131.36M | -$142.54M |
| 2016ended Dec 31, 2016 | $15M* | -$147.37M | -$141.09M |
Fiscal years as NEUROCRINE BIOSCIENCES INC reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NEUROCRINE BIOSCIENCES INC
- The revenue of NEUROCRINE BIOSCIENCES INC
- The cash flow of NEUROCRINE BIOSCIENCES INC
- The debt of NEUROCRINE BIOSCIENCES INC
- All of NEUROCRINE BIOSCIENCES INC's financials, charted
Companies of a similar size
- JAZZJazz Pharmaceuticals plc
- PFGCPerformance Food Group Company
- RBCRBC BEARINGS INCORPORATED
- WWayfair Inc.
- SWKSTANLEY BLACK & DECKER, INC.
Not investment advice. This page shows what NEUROCRINE BIOSCIENCES INC filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.